Thanks Arron. Yes, it’s appears as if Ian, the EBV Ambassador, is appreciative of your delegation.
So, Ian, I must express my gratitude and appreciation, as well.
And, seriously, after scrolling thru the thread that you linked; I can’t thank you, enough, for all that you are doing/have done.
I suppose my EBV test results should not really be much of a surprise. My daughter had actually suggested I be tested, because she had been diagnosed with it, less than six months before my MS diagnosis, two+ years ago. But, I didn’t, right away, because I had never tested positive for mono, before. Maybe my late (30 something) exposure in life, as theorized; really does have something to do with my MS diagnosis. And, hopefully, the early (teen) exposure that my daughter had will protect her from MS, too.
Will certainly be reading and re-reading the related threads, here, to be certain!
So much to study and contemplate. B-cell targeting, next.
Was also given various tests for other viruses: CMV, HSV, and Chlamydia. All were negative. Am still considering LDN. Just finished reading “Up the Creek With a Paddle.” Apparently, some with the AIDS virus think it helps. Can’t help to be glad that I was attacked by EBV, not HIV! Such things do evoke my coping mantra: “things could always be worse.”
Yes, so much left to search out.
My neurologist claims that Betaseron has anti-viral properties, too. Maybe that’s why it may have some success? Not enough for me to consent to taking it, tho. 35% success rates seem to be thrown at us, not just for all CRABS, but for most drugs that treat incurable diseases. This is the article that my husband recently gave me, about this. From Business Week:
http://images.businessweek.com/ss/06/05 ... _id=search
So, granted, maybe 35% success rates can be thrown out there for all un-conventional treatments, too. All part of a seemingly vicious cycle in attempting to treat MS, I suppose.
What also worries me, according to an article that I read yesterday (thought I saved the link, but can’t find it, now); are theories on the possible similarity of EBV genetic coding to that of Myelin. So, maybe a drug that would attack EBV, would also attack Myelin, too?!
Thanks, so much, again for all that you do…and, for helping to steer me in the right direction(s).
Minai
